Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma.

Saved in:
Bibliographic Details
Title: Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastoma.
Authors: Riemondy KA; RNA Bioscience Initiative, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Venkataraman S; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, Colorado, USA.; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Willard N; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Nellan A; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, Colorado, USA.; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Sanford B; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, Colorado, USA., Griesinger AM; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, Colorado, USA.; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Amani V; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, Colorado, USA.; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Mitra S; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, Colorado, USA.; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Hankinson TC; Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Handler MH; Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Sill M; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Ocasio J; Department of Neurology, UNC School of Medicine, Chapel Hill, North Carolina, USA., Weir SJ; Department of Neurology, UNC School of Medicine, Chapel Hill, North Carolina, USA., Malawsky DS; Department of Neurology, UNC School of Medicine, Chapel Hill, North Carolina, USA., Gershon TR; Department of Neurology, UNC School of Medicine, Chapel Hill, North Carolina, USA., Garancher A; Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA., Wechsler-Reya RJ; Tumor Initiation and Maintenance Program, NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California, USA., Hesselberth JR; RNA Bioscience Initiative, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Foreman NK; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, Colorado, USA.; Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Donson AM; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, Colorado, USA.; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Vibhakar R; Morgan Adams Foundation Pediatric Brain Tumor Research Program, Children's Hospital Colorado, Aurora, Colorado, USA.; Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Source: Neuro-oncology [Neuro Oncol] 2022 Feb 01; Vol. 24 (2), pp. 273-286.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1523-5866
DOI:10.1093/neuonc/noab135